Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

With the FDA approval of Guardant's Shield blood test last month, we are at the brink of seeing the potential of a blood test become reality.

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.

Browse 416 market data Tables and 92 Figures spread through 445 Pages and in-depth TOC on "Precision Diagnostics & Medicine ...

For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers — allowing doctors to intervene when tumors may be easier to treat. A ...

New research links a common blood test used in diabetics to determining faster Alzheimer’s decline. Find out how the TyG index could help predict brain health.

By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of aneurysms in the walls of blood vessels.